英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

TELIX    
程序名,(用户可以用来注册到BBS
或INTERNET的一套通信软件)

程式名,(用户可以用来注册到BBS 或INTERNET的一套通信软体)


请选择你想看的字典辞典：
单词字典翻译
TELIX查看　TELIX　在百度字典中的解释百度英翻中〔查看〕
TELIX查看　TELIX　在Google字典中的解释Google英翻中〔查看〕
TELIX查看　TELIX　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Telix Pharmaceuticals
    Telix is a global, commercial-stage biopharmaceutical company focused on the development of diagnostic and therapeutic (‘theranostic’) products using targeted radiation
  • Our Portfolio - Telix Pharmaceuticals
    Telix is developing targeted radiation therapies with the potential to be efficacious as stand-alone treatments or as complements to existing treatment modalities, addressing areas of high unmet medical need We pair each therapeutic with a diagnostic imaging agent This underpins the theranostic approach whereby two conjugates are used to target the same cell-surface receptor: one for
  • Our Company - Telix Pharmaceuticals
    Telix business units Telix’s business model reflects our focus as a therapeutics-led radiopharmaceutical company committed to precision oncology
  • Pipeline - Telix Pharmaceuticals
    Our core product pipeline, focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and hematology, has generated extensive clinical data that demonstrate the potential for efficacy and acceptable safety profile We believe the targets and indications we are pursuing are well validated and are well suited for the delivery of
  • News Views - Telix Pharmaceuticals
    Telix Resubmits NDA to U S FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate ASX, News Telix today announces the resubmission of a New Drug Application (NDA) to the United States (U S ) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara®, Floretyrosine F 18 or 18F-FET), an investigational… Read more
  • Telix to Acquire RLS to Expand North American Manufacturing and . . .
    Telix and RLS (USA) Inc , America’s only Joint Commission-accredited radiopharmacy network distributing PET [1], SPECT [2] and therapeutic radiopharmaceuticals, today announced an agreement by the Company to acquire RLS from its parent company, RLS Group Ltd The acquisition significantly expands Telix’s North American manufacturing footprint and establishes the basis of a next generation
  • 2024 Annual Report
    Message from CEO “Having built a strong foundation over the last few years, and with several major inflection points achieved in 2024, we are on the cusp of exponential growth I believe that Telix can be the global leader of this rapidly growing field of medicine, setting the standard and charting the course ahead for radiopharmaceuticals to change the way we ‘see and treat’ cancer
  • Careers - Telix Pharmaceuticals
    Being a Telix employee means being a part of a unique global interdisciplinary team working to deliver what’s next in precision medicine through targeted radiation
  • Telix Resubmits NDA to U. S. FDA for TLX101-Px (Pixclara®) Brain Cancer . . .
    Telix today announces the resubmission of a New Drug Application (NDA) to the United States (U S ) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara® [1], Floretyrosine F 18 or 18 F-FET), an investigational PET [2] imaging agent for the characterization of recurrent or progressive glioma (brain cancer) from treatment related changes in both adult and pediatric patients
  • Telix Reports $204M Revenue, Up 63% YOY - telixpharma. com
    Telix received country-level approvals for Illuccix in France, Finland, Ireland, Sweden, Germany, Portugal, Greece, the Czech Republic, Belgium and Italy in Q2 and is launching on a market-by-market basis, as reimbursement is secured





中文字典-英文字典  2005-2009